Successful clearance of hepatitis C virus with pegylated interferon α-2a and ribavirin in an etanercept-treated patient with psoriatic arthritis, hepatitis B virus coinfection and latent tuberculosis. [electronic resource]
Producer: 20110824Description: 1343-4 p. digitalISSN:- 1468-2060
- Adult
- Antiviral Agents -- therapeutic use
- Arthritis, Psoriatic -- drug therapy
- Drug Therapy, Combination
- Etanercept
- Hepatitis B, Chronic -- complications
- Hepatitis C, Chronic -- drug therapy
- Humans
- Immunoglobulin G -- therapeutic use
- Immunosuppressive Agents -- therapeutic use
- Interferon alpha-2
- Interferon-alpha -- therapeutic use
- Latent Tuberculosis -- complications
- Male
- Polyethylene Glycols -- therapeutic use
- Receptors, Tumor Necrosis Factor -- therapeutic use
- Recombinant Proteins
- Ribavirin -- therapeutic use
No physical items for this record
Publication Type: Case Reports; Letter; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.